Caldera Therapeutics

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttp://www.calderatx.com/

Last Round

Series A

Extension

Jan 14, 2026

Total Funding Raised

$112.5M

Company Overview

Caldera Therapeutics is a clinical stage biotechnology company developing CLD-423, a first-in-class bispecific antibody for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

bispecific antibodyIBD therapyinflammatory bowel diseaseIBDclinical stage biotechimmunologyfirst-in-class drugTL1A inhibitorIL-23 inhibitordual-target therapyulcerative colitisCrohn's diseasedrug licensingbiologicsPhase 1 clinical trial

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Caldera Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Caldera Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Caldera Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Jan 14, 2026
Series A	Apr 23, 2025

View all Funding Rounds

Caldera Therapeutics Investors

Notable investors and investment history

Caldera Therapeutics investors
Investor	Rounds
Janus Henderson Group	Series A Extension
Omega Funds	Series A Extension
Accomplice	Series A Extension, Series A
venBio	Series A Extension, Series A
Wellington Management	Series A Extension

View all Investors

Caldera Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Caldera Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Caldera Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Year Founded2025

Last FundingJan 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.